Introduction
- 1 January 2000
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 49 (S1) , 1-3
- https://doi.org/10.1046/j.1365-2125.2000.00146.x
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Ziprasidone in the long-term treatment of negative symptoms and prevention of exacerbation of schizophreniaEuropean Psychiatry, 1998
- P.2.084 Effects of oral ziprasidone and risperidone on cognitive functioning in patients with schizophrenia or schizoaffective disorder: Preliminary dataEuropean Neuropsychopharmacology, 1997
- Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus HaloperidolThe British Journal of Psychiatry, 1995
- Risperidone in the treatment of schizophreniaAmerican Journal of Psychiatry, 1994
- Newer Antipsychotic DrugsDrugs, 1993
- A predictive model for substrates of cytochrome P450-debrisoquine (2D6)Chemical Research in Toxicology, 1992
- The Mechanism of Action of Novel Antipsychotic DrugsSchizophrenia Bulletin, 1991
- Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PETScience, 1986
- Antipsychotic Drugs, Neurotransmitters, and SchizophreniaAmerican Journal of Psychiatry, 1978